U.S. stocks traded lower Thursday, with the Nasdaq Composite down more than 150 points, while Everpure, Inc. (NYSE:P) climbed 14% to $125.65 after outlining a broader growth strategy at its 2026 Financial Analyst Meeting. The data storage company reaffirmed its fiscal 2027 outlook and issued a preliminary fiscal 2028 outlook as it expands into artificial intelligence, data software and hyperscale markets, which serve very large-scale computing operations. Other gainers included Securitize Corp, Lufax Holding Ltd – ADR, Chaince Digital Holdings Inc., Fervo Energy Co, Arcturus Therapeutics Holdings Inc, Quantum Corp, Gran Tierra Energy Inc, Ginkgo Bioworks Holdings Inc, Charles River Laboratories Intrtnl, Inc. and Bally's Corp. Chaince Digital repurchased and cancelled warrants for $2.0 million in cash, while Fervo said Cape Station achieved First Power. Arcturus reported interim Phase 2 results from ARCT-810 in OTC deficiency, introduced LUNAR 2.0 and announced plans to acquire myNEO. Charles River Laboratories International reiterated its FY26 revenue and non-GAAP earnings outlook and expects FY30 organic revenue growth of 5% to 7%.